Dodge & Cox, an investment management firm, reduced its stake in Eli Lilly and Company by 3.5% in the third quarter of 2026, selling 1,573 shares. This reduction, though small, could indicate a change in the firm’s investment strategy or outlook on the pharmaceutical company’s future. Eli Lilly’s stock has seen significant gains, rising from around $623 to over $1,000 in the past year.
Dodge & Cox Sells 1,573 Shares of Eli Lilly and Company
Dodge & Cox, an investment management firm, reduced its stake in Eli Lilly and Company by 3.5% in the third quarter of 2026, selling 1,573 shares. This reduction, though small, could indicate a change in the firm’s investment strategy or outlook on the pharmaceutical company’s future. Eli Lilly’s stock has seen significant gains, rising from around $623 to over $1,000 in the past year.